Aerie Pharmaceuticals Inc (AERI) Return on Assets ROA from the third quarter of 2022 to third quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aerie Pharmaceuticals Inc   (NASDAQ: AERI)


Aerie Pharmaceuticals Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Aerie Pharmaceuticals Inc 's ROA in the third quarter of 2022?
Aerie Pharmaceuticals Inc recorded a cumulative net loss of $-37 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -9.7%.

However, within the Healthcare sector 319 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 3808, from total ROA ranking in the second quarter of 2022 at 4113.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Total Assets Change 8.03 % 6.26 % 7.52 % 5.43 % -6.22 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -37 -49 -69 -75 -166
Return On Assets (TTM) -9.7 % -13.35 % -18.84 % -20.88 % -47.15 %
AERI's Total Ranking # 3808 # 4113 # 4290 # 4632 # 4341
Total Assets (TTM) in million 356 365 376 410 330
Seq. Total Assets Change -2.5 % -2.91 % -8.28 % 24.42 % -4.1 %
Seq. Net Income Change - - - - -

AERI's 5 Years Annual ROA >> Back to AERI Management Effectiveness >> Compare AERI ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 33
Sector # 320
Overall # 3730

Return On Assets Statistics
High Average Low
197.2 %
-31.12 %
-85.01 %
(Mar 31 2014)   (Jun 30 2019)





Financial Statements
Aerie Pharmaceuticals Inc 's Assets $ 356 million AERI's Balance sheet
Aerie Pharmaceuticals Inc 's Income $ -27 million Quarterly AERI's Income Statement
AERI's Income by Division See AERI's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017
Y / Y Total Assets Change 5.43 % -14.03 % 58.74 % -1.8 % 16.93 %
Total Assets in million 410 389 452 285 290
Y / Y Net Income Change - - - - -
Net Income in million -75 -183 -200 -233 -145
Annual Return On Assets -18.24 % -47.07 % -44.11 % -81.59 % -49.99 %

AERI's 5 Years Annual ROA >> Back to AERI Management Effectiveness >> Compare AERI ROA to its Competitors



More Return On Assets Ratios
AERI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AERI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AERI's Competitors
Subscribers only: Roa for Aerie Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for AERI's Customers

You may also want to know
AERI's Roi AERI's Inventory Turnover Ratio AERI's Growth Rates AERI's Dividend Comparisons
AERI's Profitability Ratios AERI's Asset Turnover Ratio AERI's Dividend Growth
AERI's Roe AERI's Valuation Ratios AERI's Financial Strength Ratios AERI's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA

Date modified: 2026-08-29T17:18:16+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.